Elite Pharma Inc
(ELTP)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2000 | 03-1999 | |
| Cash Flows From Operating Activities | ||
| Net Income | -2,976 | -1,660 |
| Depreciation Amortization | 86 | 50 |
| Other Working Capital | 111 | 150 |
| Other Operating Activity | 0 | 10 |
| Operating Cash Flow | $-2,779 | $-1,450 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -2,425 | -1,070 |
| Purchase Sale Intangibles | -14 | N/A |
| Other Investing Activity | -885 | -190 |
| Investing Cash Flow | $-3,310 | $-1,260 |
| Cash Flows From Financing Activities | ||
| Debt Issued | 3,000 | N/A |
| Debt Repayment | -245 | N/A |
| Common Stock Issued | 5,790 | N/A |
| Other Financing Activity | -78 | -60 |
| Financing Cash Flow | $8,467 | $-60 |
| Beginning Cash Position | 1,559 | 4,340 |
| End Cash Position | 3,937 | 1,550 |
| Net Cash Flow | $2,378 | $-2,780 |
| Free Cash Flow | ||
| Operating Cash Flow | -2,779 | -1,450 |
| Capital Expenditure | -2,425 | N/A |
| Free Cash Flow | -5,204 | -1,450 |